| Financial Year |
March 31 2023 |
| Monetary Funds |
446,246,679.10 |
| Held-for-trading Financial Assets |
151,271,506.86 |
| Notes Receivable |
-- |
| Accounts Receivable |
7,177,031.55 |
| Advances to Suppliers |
28,179,253.51 |
| Other Receivables |
51,799,184.64 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
658,043,363.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
4,431,243.16 |
| Other Current Assets |
16,825,826.47 |
| Total Current Assets |
1,363,974,088.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
42,749,901.91 |
| Long-term Equity Investment |
-- |
| Investment Properties |
117,401,351.78 |
| Fixed Assetes |
897,925,378.55 |
| Under-construction Projects |
24,989,159.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
83,015,985.31 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
75,755,966.83 |
| Deferred Income Tax Assets |
195,292.18 |
| Other Non-Current Assets |
255,911,314.83 |
| Sub-Total of Non-Current Assets |
3,318,974,232.67 |
| Total Assets |
4,682,948,321.00 |
| Short-Term Loans |
115,080,972.20 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,031,527,107.44 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
32,705,405.93 |
| Taxes Payable |
5,835,292.80 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
224,811,164.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
220,833,267.81 |
| Other Current Liabilities |
145,585,201.85 |
| Sub-Total of Current Liabilities |
2,749,371,633.80 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
65,883,560.61 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,921,278,975.04 |
| Total Liabilities |
4,670,650,608.84 |
| Paid-In Capital(Or Share Stock) |
440,000,000.00 |
| Capital Surplus |
2,435,898,081.65 |
| Surplus Reserve |
206,267,572.49 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-3,070,102,302.92 |
| Minority Stockholder's Interest |
234,360.94 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,063,351.22 |
| Owner's Equity（Stockholder's Equity） |
12,297,712.16 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,682,948,321.00 |
